Current therapy for leishmaniasis is not satisfactory. We describe the in vitro antiproliferative effects of new thiadiazine derivatives against Leishmania amazonensis. The compounds were found to be active against the amastigote form of the parasite, inhibiting parasite growing, from 10 to 89%, at a concentration of 100 ng/ml. This activity suggests that thiadiazine derivatives could be considered as potential antileishmanial compounds
Current treatments for cutaneous and visceral leishmaniasis are toxic, expensive, difficult to admin...
Leishmania mexicana promastigote and intracellular amastigote growths were inhibited by the water-so...
Leishmaniasis is one of the world's most neglected diseases, and it has a worldwide prevalence of 12...
Current therapy for leishmaniasis is not satisfactory. We describe the in vitro antiproliferative e...
AbstractLeishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand f...
The spectrum and efficacy of available antileishmanial drugs is limited. In the present work we eva...
The spectrum and efficacy of available antileishmanial drugs is limited. In the present work we eval...
Neglected tropical diseases affect the lives of a billion people worldwide. Among them, the parasiti...
During last decades, 3,5-disubstituted-tetrahydro-2H-thiadiazine-2-thione scaffold remains the cente...
Cutaneous leishmaniasis (CL) is a neglected tropical disease, which causes severe skin lesions. Due ...
OBJECTIVES: To evaluate the in vitro leishmanicidal activity of imidazole-based (1-4) and pyrazole-b...
Cytotoxicity assays of 24 new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives ...
Basing on a library of thiadiazole derivatives showing anti-trypanosomatidic activity, we have consi...
Leishmania mexicana promastigote and intracellular amastigote growths were inhibited by the water-so...
Leishmaniasis is one of the world’s most neglected diseases, and it has a worldwide prevalence of 12...
Current treatments for cutaneous and visceral leishmaniasis are toxic, expensive, difficult to admin...
Leishmania mexicana promastigote and intracellular amastigote growths were inhibited by the water-so...
Leishmaniasis is one of the world's most neglected diseases, and it has a worldwide prevalence of 12...
Current therapy for leishmaniasis is not satisfactory. We describe the in vitro antiproliferative e...
AbstractLeishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand f...
The spectrum and efficacy of available antileishmanial drugs is limited. In the present work we eva...
The spectrum and efficacy of available antileishmanial drugs is limited. In the present work we eval...
Neglected tropical diseases affect the lives of a billion people worldwide. Among them, the parasiti...
During last decades, 3,5-disubstituted-tetrahydro-2H-thiadiazine-2-thione scaffold remains the cente...
Cutaneous leishmaniasis (CL) is a neglected tropical disease, which causes severe skin lesions. Due ...
OBJECTIVES: To evaluate the in vitro leishmanicidal activity of imidazole-based (1-4) and pyrazole-b...
Cytotoxicity assays of 24 new 3,5-disubstituted-tetrahydro-2H-1,3,5-thiadiazin-2-thione derivatives ...
Basing on a library of thiadiazole derivatives showing anti-trypanosomatidic activity, we have consi...
Leishmania mexicana promastigote and intracellular amastigote growths were inhibited by the water-so...
Leishmaniasis is one of the world’s most neglected diseases, and it has a worldwide prevalence of 12...
Current treatments for cutaneous and visceral leishmaniasis are toxic, expensive, difficult to admin...
Leishmania mexicana promastigote and intracellular amastigote growths were inhibited by the water-so...
Leishmaniasis is one of the world's most neglected diseases, and it has a worldwide prevalence of 12...